D-0434-2022 Class II Terminated

Recalled by Edge Pharma, LLC — Colchester, VT

FDA drug recall D-0434-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 63 vials.

Recall details

Product Type
Drugs
Report Date
Feb 2, 2022
Initiation Date
Dec 6, 2021
Termination Date
Jun 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
63 vials

Product description

Dibutyl Squaric Acid, Topical Solution (PF), Multiple Dose Vial, 2%, 10 mL per vial, Edge Pharma, LLC, 856 Hercules Dr, Colchester VT, 05446, NDC 05446-1047-03

Reason for recall

CGMP Deviations

Distribution pattern

nationwide

Code information

09-2021-15@5 12-14-2021 & 10-2021-01@4 12-30-2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0434-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0434-2022. Report a data issue: hello@regdatalab.com.